ChatGPT-4o Responses to Patient Questions

ChatGPT-4o Responses to Patient Questions

Up next

Autofluorescence in Retinal Detachments

Dr. Rukhsana Mirza sits down with Dr. Avni P. Finn to discuss her Ophthalmology Science article, "Ultra-Widefield Fundus Autofluorescence Findings as an Indicator of Duration in Rhegmatogenous Retinal Detachment," which used ultra-widefield color fundus photography and fundus aut ...  Show more

Rate and Rationale for Vitrectomy after Pneumatic Retinopexy

Dr. Rajesh Rao interviews Dr. Bradley T. Smith on his study to report the rate and rationale for vitrectomy after retinal detachment repair with pneumatic retinopexy, from his Ophthalmology Retina article, "Rate and Rationale for Vitrectomy after Pneumatic Retinopexy." Rate and R ...  Show more

Recommended Episodes

#192 Debate on First-Line Medications for Diabetes
Core IM | Internal Medicine Podcast

SGLT-2i vs. GLP-1? vs Metformin? How do you balance the cost and coverage of first-line options like metformin, SGLT-2, and GLP-1s? How do you choose between SGLT-2 and GLP-1s for comorbidities like CAD or CKD? And how do you weigh their side effects and practical use?🔹 Sponsor: ...  Show more

#337 - Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment | Ralph DeFronzo, M.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/ ...

  Show more

S3 Episode 2: Treating Type 2 Diabetes in an Aging Population: Geriatric Syndromes, Comorbidities, and Treatment De-escalation
Medscape InDiscussion: Type 2 Diabetes

Drs Carol H. Wysham and Medha Munshi discuss type 2 diabetes in older adults, understanding geriatric syndromes and how they impact care, and when to de-escalate treatment. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ...  Show more

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Annals On Call Podcast

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.